Figure 5From: Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the ratBody weight gain (A) and food consumption (B) after 2 days GAlbudAb treatment. Values are presented as mean ± SEM. **p < 0.01 and ****p < 0.0001 vs. vehicle.Back to article page